| Wu, Yu M |
NCT05229809: Clinical Trial of Yiqi Wenyang Jiedu Prescription in the Prevention and Treatment of Postoperative Metastasis and Recurrence of Gastric Cancer |
|
|
| Recruiting | 4 | 212 | RoW | Yiqi Wenyang Jiedu prescription, Simulation agent of Yiqi Wenyang Jiedu prescription | Jie Li | Gastric Carcinoma | 07/23 | 07/24 | | |
NCT05219617 / 2022-001256-42: Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults |
|
|
| Recruiting | 3 | 252 | Europe, US, RoW | Carisbamate | SK Life Science, Inc., SK Life Science, Inc | Seizures, Lennox Gastaut Syndrome | 06/25 | 06/26 | | |
NCT05187481: Effect of Jianpi Huatan Decoction on Advanced Colorectal Cancer |
|
|
| Recruiting | 3 | 200 | RoW | Jianpi Huatan dispensing granule, Placebo granule | Xiyuan Hospital of China Academy of Chinese Medical Sciences, China Academy of Chinese Medical Sciences, Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Colorectal Neoplasms | 07/24 | 07/24 | | |
NCT06051409: A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ALL. |
|
|
| Recruiting | 3 | 350 | RoW | Olverembatinib, Imatinib | Ascentage Pharma Group Inc., HealthQuest Pharma Inc. | Ph+ ALL | 12/24 | 10/28 | | |
NCT05709093: A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-naïve Patients With Higher-risk Myelodysplastic Syndrome (MDS) |
|
|
| Recruiting | 3 | 552 | RoW | Lemzoparlimab+Azacitidine (AZA), Azacitidine (AZA) | TJ Biopharma Co., Ltd. | Myelodysplastic Syndromes(MDS) | 03/27 | 03/27 | | |
TQB2618- I -02, NCT05426798: Clinical Study of TQB2618 Injection in Combination With Demethylation Drugs in Patients With Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes |
|
|
| Recruiting | 1 | 73 | RoW | TQB2618 injection azacitidine, AZA decitabine, DAC | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes | 09/23 | 12/23 | | |
NCT05924750: A Study of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia |
|
|
| Recruiting | 1 | 26 | RoW | BL-M11D1 | Sichuan Baili Pharmaceutical Co., Ltd. | Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) | 08/25 | 08/25 | | |
NCT03273920: Robotic Versus Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer |
|
|
| Not yet recruiting | N/A | 1110 | RoW | Robotic distal gastrectomy with D2 nodal dissection, Laparoscopic distal gastrectomy with D2 nodal dissection | Southwest Hospital, China, Chinese PLA General Hospital, West China Hospital, Xijing Hospital of Digestive Diseases, Nanjing PLA General Hospital, Peking University Cancer Hospital & Institute, Qingdao University, Fujian Medical University Union Hospital, Central South University, The First Affiliated Hospital of Nanchang University, Sun Yat-sen University, Wuhan Union Hospital, China, Jilin Provincial Tumor Hospital, Lanzhou General Hospital of PLA | Gastric Cancer | 09/19 | 09/22 | | |
| Recruiting | N/A | 3500 | RoW | | Tang-Du Hospital, Esaote (Shenzhen) Medical Equipment Co. Ltd, The First Affiliated Hospital, Zhejiang University School of Medicine, Shannxi Provincial People's Hospital, Shengjing Hospital, First Hospital of China Medical University, Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Renmin Hospital of Wuhan University, Beijing University of Chinese Medicine Third Affiliated Hospital, The First Affiliated Hospital of Shanxi Medical University, The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, The First Hospital of Jilin University, The Afffiliated Hospital of Guizhou Medical University, Yan An Hospital Affiliated to Kunming Medical University, Second Affiliated Hospital of Guangzhou Medical University, Third Xiangya Hospital of Central South University, Ruijin Hospital, The First Affiliated Hospital with Nanjing Medical University, The First Affiliated Hospital of Anhui Medical University, The Second Hospital of Anhui Medical University, The First Affiliated Hospital of USTC, The Affiliated Hospital of Qingdao University, First Affiliated Hospital of Xinjiang Medical University, Hospital of Northwestern Polytechnical University, GEM Flower Xian Changqing Staff Hospital, Xi'an Central Hospital, The Second Affiliated Hospital of Xi'an Medical University, Second Affiliated Hospital of Xi'an Jiaotong University, First Affiliated Hospital of Guangxi Medical University, Karamay Central Hospital of Xinjiang, The Fourth Affiliated Hospital of Xinjiang Medical University, Xi'an No.1 Hospital, Xianyang Hospital of Yan'an University, General Hospital of Xinjiang Production and Construction Corps, Air Force Medical Center | Healthy, Adults, Carotid Intima-media Thickness, Vascular Stiffness, Chinese | 05/22 | 05/22 | | |
NCT06469034: Mixed Reality and Head-mounted Display for Central Venous Catheterization |
|
|
| Recruiting | N/A | 124 | RoW | conventional ultrasound, Mixed reality and head-mounted display ultrasound | The Second Hospital of Anhui Medical University | Central Venous Catheterization | 06/25 | 06/25 | | |
NCT05626309: Clinical Trial of Qizhu Yuling Prescription in the Prevention and Treatment of Esophagus Cancer |
|
|
| Recruiting | N/A | 310 | RoW | Qizhu Yuling Prescription, Placebo, Simulation agent of Qizhu Yuling Prescription | Jie Li | Esophagus Cancer | 08/24 | 11/24 | | |
| Recruiting | N/A | 80 | RoW | Tyrosine kinase inhibitor drugs., TKI treatment | Fujian Cancer Hospital | Thyroid Cancer, Tyrosine Kinase Inhibitor, Health Related Quality of Life | 01/25 | 01/26 | | |
| Tang, xudong |
NCT04340297: Tongjiang Series Prescription Combined With PPIs Descending Ladder Withdrawal in Treating Nonerosive Reflux Disease |
|
|
| Recruiting | 3 | 180 | RoW | Tongjiang series prescription(Tongjiang granules, Jianpi Qinghua granules and Wenpi Qingwei granules), Acid inhibitors, Placebo | Xiyuan Hospital of China Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Traditional Chinese Medicine, Wuhan No.1 Hospital, The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Traditional Chinese Medicine Hospital of KUNSHAN, Liuzhou Hospital of Traditional Chinese Medicine | Nonerosive Reflux Disease | 12/21 | 12/21 | | |
NCT05369884: Efficacy and Safety of WPQW Granule for Overlap of NERD and IBS-D |
|
|
| Recruiting | 1 | 216 | RoW | WPQW granule, WPQW granule simulant | Xiyuan Hospital of China Academy of Chinese Medical Sciences, Tianjin Nankai Hospital, the first affiliated hospital of Liaoning university of traditional Chinese medicine, The First Affiliated Hospital of Shanxi University of Traditional Chinese Medicine, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Yunnan Provinical Hospital of Traditional Chinese Medicine | Non-erosive Reflux Disease, Diarrhea-Predominant Irritable Bowel Syndrome | 05/23 | 05/23 | | |
| Zhu, Yanhong |
NCT05841771: Hypomethylating Agent and Venetoclax After Allo-HSCT in Patients With High-risk Myeloid Malignancies. |
|
|
| Recruiting | 2 | 78 | RoW | Venetoclax, BCL-2 inhibitor, Azacitidine or decitabine, Hypomethylating Agent | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Hypomethylating Agent, Venetoclax, Myeloid Malignancy | 12/24 | 12/25 | | |
| Zhuang, Baixi |
GENIUS, NCT04849325: IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease |
|
|
| Recruiting | N/A | 120 | RoW | Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System (IBS Titanâ„¢), Percutaneous Transluminal Angioplasty (PTA) Device | Biotyx Medical (Shenzhen) Co., Ltd. | Critical Limb Ischemia (CLI) | 04/24 | 10/24 | | |
